TrialThe Lancet. Oncology2025

Microbubble-enhanced transcranial focused ultrasound with temozolomide for patients with high-grade glioma (BT008NA): a multicentre, open-label, phase 1/2 trial.

Graeme F Woodworth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.